Pages that link to "Glossary:TAG-00018-Inv-die"

The following pages link to Glossary:TAG-00018-Inv-die:

Displaying 50 items.

• Glossary (← links)
• Reference:DEU MBO - Berufsordnung der Ärzt:innen 11-Jun-2021 § 15 (← links)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 42a (← links)
• Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.109 (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Service Provider (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Sponsor-Investigator (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - sponsor (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.17 (← links)
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (f) (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.3 (b) - Sponsor-Investigator (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.50 (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.53 (← links)
• Reference:USA 21 CFR Part 54 09-Apr-2025 § 54.4 list of investigators (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.3 (o) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.43 (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Investigator (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2 (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - investigator (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 1.4 (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.2 (← links)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 4 Absatz 25 (← links)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 30-001 (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 investigator (← links)
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (d) (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.3 - Investigator (← links)
• Reference:USA 21 CFR Part 54 09-Apr-2025 § 54.4 disclosure (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.60-001 (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.3 (i) (← links)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 49 (← links)
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 58 Paragraph 7 – 8 (← links)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 3 Absatz 5 – 6 (← links)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 30-002 (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.2 (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 15 (5) (d) (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 3.5 (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 3.14-001 (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.11 (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.53 (c) (← links)
• Reference:WHO WHO - HANDBOOK FOR GOOD CLINICAL RESEARCH PRACTICE (GCP) 2005 Page 60-61 (← links)
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.20 (← links)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40b Absatz 2 (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.70 (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.119 (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 4 (← links)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 41 (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.30 (← links)
• Reference:EU EMA/786433/2022 Annex V – to guidance for the conduct of good clinical practice inspections – Phase I units 15-Nov-2022 2.5-002 (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.68 (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.145 (← links)
• Reference:USA NCI GUIDELINES FOR INVESTIGATORS: ADVERSE EVENT REPORTING REQUIREMENTS FOR DCTD (CTEP AND CIP) INDs AND IDEs 30-Aug-2024 2.1.2 (← links)